Agilent Technologies Inc. (A) News
Filter A News Items
A News Results
|Loading, please wait...|
A News Highlights
- For A, its 30 day story count is now at 51.
- Over the past 26 days, the trend for A's stories per day has been choppy and unclear. It has oscillated between 1 and 15.
- GOLD, BEAT and MOS are the most mentioned tickers in articles about A.
Latest A News From Around the Web
Below are the latest news stories about Agilent Technologies Inc that investors may wish to consider to help them evaluate A as an investment opportunity.
Marijuana penny stocks may rally violently if optimism returns to the cannabis industry.
SANTA CLARA, Calif., February 24, 2022--Agilent Technologies Inc. (NYSE: A) today announced that Bob McMahon, senior vice president and chief financial officer, will participate in Q&A sessions at the Cowen 42nd Annual Health Care Conference and the Barclays Global Health Care Conference. Below are the details:
Agilent (A) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
SANTA CLARA, Calif. & BURLINGTON, Vt., February 24, 2022--Agilent Technologies Inc. (NYSE: A) and the University of Vermont (UVM) today announced the establishment of the Agilent Laboratory for Chemical Analysis (ALCA). The facility will be a hub for advanced instrumentation that will allow students, institutional colleagues, industrial partners, and regional high-tech start-ups to study the composition and structure of chemical samples. It is intended as a shared educational and research space
The following slide deck was published by Agilent Technologies, Inc. in conjunction with their 2022 Q1 earnings call....
View more earnings on ASee more from BenzingaCerus Reports Narrower Quarterly Loss As INTERCEPT Platelet Kits Lift Q4 SalesMarinus Pharma Delays Status Epilepticus, IV Ganaxolone Clinical Trials Into 2023© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Agilent's (A) fiscal first-quarter results benefit from solid momentum across all operating segments. Further, strong growth in the pharma market remains a tailwind.
SANTA CLARA, Calif., February 23, 2022--Agilent Technologies Inc. (NYSE: A) announced today that researchers from the QIMR Berghofer Medical Research Institute in Brisbane, Australia, collaborated with Agilent experts on a proof-of-concept FTIR-based saliva COVID-19 testing workflow using the Agilent Cary 630 FTIR Spectrometer.
Agilent Technologies press release (NYSE:A): Q1 Non-GAAP EPS of $1.21 beats by $0.03. Revenue of $1.67B (+7.7% Y/Y) beats by $10M. Full year revenue is expected to be in the range of $6.67 billion to $6.73 billion vs. $6.73B consensus, representing reported growth of 5.6% to 6.5%, and core(1) growth of 7.0%...
Costco shares are priced at 44 times earnings, but investors rushed to "buy the dip" when it fell recently.